ORIGINAL ARTICLE

Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma

C Ward³, M Pais¹, R Bish¹, D Reid¹, B Feltis¹, D Johns², E H Walters²

¹ Department of Respiratory Medicine, The Alfred Hospital and Monash University, Melbourne, Australia
² Discipline of Medicine, University of Tasmania Medical School, Hobart, Tasmania, Australia
³ William Leech Centre, Freeman Road Hospital, University of Newcastle upon Tyne, UK

Correspondence to:
Correspondence to:
Professor E H Walters, Department of Clinical Sciences, University of Tasmania Medical School, Hobart, Tasmania, Australia 7001;
haydn.walters{at}utas.edu.au

Background: There are few data in asthma relating airway physiology, inflammation and remodelling and the relative effects of inhaled corticosteroid (ICS) treatment on these parameters. A study of the relationships between spirometric indices, airway inflammation, airway remodelling, and bronchial hyperreactivity (BHR) before and after treatment with high dose inhaled fluticasone propionate (FP 750 µg bd) was performed in a group of patients with relatively mild but symptomatic asthma.

Methods: A double blind, randomised, placebo controlled, parallel group study of inhaled FP was performed in 35 asthmatic patients. Bronchoalveolar lavage (BAL) and airway biopsy studies were carried out at baseline and after 3 and 12 months of treatment. Twenty two normal healthy non-asthmatic subjects acted as controls.

Results: BAL fluid eosinophils, mast cells, and epithelial cells were significantly higher in asthmatic patients than in controls at baseline (p<0.01). Subepithelial reticular basement membrane (rbm) thickness was variable, but overall was increased in asthmatic patients compared with controls (p<0.01). Multiple regression analysis explained 40% of the variability in BHR, 21% related to rbm thickness, 11% to BAL epithelial cells, and 8% to BAL eosinophils. The longitudinal data corroborated the cross sectional model. Forced expiratory volume in 1 second improved after 3 months of treatment with FP with no further improvement at 12 months. PD₂₀ improved throughout the study. BAL inflammatory cells decreased following 3 months of treatment with no further improvement at 12 months (p<0.05 v placebo). Rbm thickness decreased in the FP group, but only after 12 months of treatment (mean change –1.9, 95% CI –3 to –0.7 µm; p<0.01 v baseline, p<0.05 v placebo). A third of the improvement in BHR with FP was associated with early changes in inflammation, but the more progressive and larger improvement was associated with the later improvement in airway remodelling.

Conclusion: Physiology, airway inflammation and remodelling in asthma are interrelated and improve with ICS. Changes are not temporally concordant, with prolonged treatment necessary for maximal benefit in remodelling and PD₂₀. Determining the appropriate dose of inhaled steroids only by reference to symptoms and lung function, as specified in current international guidelines, and even against indices of inflammation may be over simplistic. The results of this study support the need for early and long term intervention with ICS, even in patients with relatively mild asthma.

Keywords: asthma; inhaled corticosteroids; airway inflammation; airway remodelling; fluticasone

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Bourdin, A, Gras, D, Vachier, I, Chanez, P (2009). Upper airway {middle dot} 1: Allergic rhinitis and asthma: united disease through epithelial cells. Thorax 64: 999-1004 [Abstract] [Full Text]  
• Montuschi, P., Pagliari, G., Fuso, L. (2009). Pharmacotherapy of asthma: regular treatment or on demand?. Ther Adv Respir Dis 3: 175-191 [Abstract]  
• Motomura, C., Odajima, H., Tezuka, J., Murakami, Y., Moriyasu, Y., Kando, N., Taba, N., Hayashi, D., Okada, K., Nishima, S. (2009). Effect of Age on Relationship Between Exhaled Nitric Oxide and Airway Hyperresponsiveness in Asthmatic Children. Chest 136: 519-525 [Abstract] [Full Text]  
• Derom, E., Louis, R., Tiesler, C., Engelstatter, R., Kaufman, J-M., Joos, G. F. (2009). Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma. Eur Respir J 33: 1277-1286 [Abstract] [Full Text]  
• Johnson, J. R., Pacitto, S. R., Wong, J., Archer, E. W., Eirefelt, S., Miller-Larsson, A., Jordana, M. (2008). Combined budesonide/formoterol therapy in conjunction with allergen avoidance ameliorates house dust mite-induced airway remodeling and dysfunction. Am. J. Physiol. Lung Cell. Mol. Physiol. 295: L780-L788 [Abstract] [Full Text]  
• Berry, M., Morgan, A., Shaw, D. E, Parker, D., Green, R., Brightling, C., Bradding, P., Wardlaw, A. J, Pavord, I. D (2007). Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax 62: 1043-1049 [Abstract] [Full Text]  
• Shepherd, M. C., Duffy, S. M., Harris, T., Cruse, G., Schuliga, M., Brightling, C. E., Neylon, C. B., Bradding, P., Stewart, A. G. (2007). KCa3.1 Ca2+Activated K+ Channels Regulate Human Airway Smooth Muscle Proliferation. Am. J. Respir. Cell Mol. Bio. 37: 525-531 [Abstract] [Full Text]  
• Saglani, S., Payne, D. N., Zhu, J., Wang, Z., Nicholson, A. G., Bush, A., Jeffery, P. K. (2007). Early Detection of Airway Wall Remodeling and Eosinophilic Inflammation in Preschool Wheezers. Am. J. Respir. Crit. Care Med. 176: 858-864 [Abstract] [Full Text]  
• Walters, E. H., Reid, D. W., Johns, D. P., Ward, C. (2007). Nonpharmacological and pharmacological interventions to prevent or reduce airway remodelling. Eur Respir J 30: 574-588 [Abstract] [Full Text]  
• Nuijsink, M., Hop, W. C. J., Sterk, P. J., Duiverman, E. J., de Jongste, J. C., on behalf of the Children Asthma Therapy Optimal (, (2007). Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial. Eur Respir J 30: 457-466 [Abstract] [Full Text]  
• Downie, S. R, Salome, C. M, Verbanck, S., Thompson, B., Berend, N., King, G. G (2007). Ventilation heterogeneity is a major determinant of airway hyperresponsiveness in asthma, independent of airway inflammation. Thorax 62: 684-689 [Abstract] [Full Text]  
• Berend, N., Salome, C. (2007). Can a Deep Breath Blow Away the Fog Surrounding Airway Hyperresponsiveness?. Am. J. Respir. Crit. Care Med. 176: 109-111 [Full Text]  
• James, A. L., Wenzel, S. (2007). Clinical relevance of airway remodelling in airway diseases. Eur Respir J 30: 134-155 [Abstract] [Full Text]  
• Lloyd, C. M., Robinson, D. S. (2007). Allergen-induced airway remodelling. Eur Respir J 29: 1020-1032 [Abstract] [Full Text]  
• Feltis, B N, Wignarajah, D, Reid, D W, Ward, C, Harding, R, Walters, E H (2007). Effects of inhaled fluticasone on angiogenesis and vascular endothelial growth factor in asthma. Thorax 62: 314-319 [Abstract] [Full Text]  
• Saglani, S., Molyneux, C., Gong, H., Rogers, A., Malmstrom, K., Pelkonen, A., Makela, M., Adelroth, E., Bush, A., Payne, D. N. R., Jeffery, P. K. (2006). Ultrastructure of the reticular basement membrane in asthmatic adults, children and infants. Eur Respir J 28: 505-512 [Abstract] [Full Text]  
• Bergeron, C., Boulet, L.-P. (2006). Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation.. Chest 129: 1068-1087 [Abstract] [Full Text]  
• Ernst, P (2006). Inhaled corticosteroids moderate lung function decline in adults with asthma. Thorax 61: 93-94 [Full Text]  
• Miller, M., Cho, J. Y., McElwain, K., McElwain, S., Shim, J. Y., Manni, M., Baek, J. S., Broide, D. H. (2006). Corticosteroids prevent myofibroblast accumulation and airway remodeling in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 290: L162-L169 [Abstract] [Full Text]  
• Pijnenburg, M. W., Bakker, E. M., Hop, W. C., De Jongste, J. C. (2005). Titrating Steroids on Exhaled Nitric Oxide in Children with Asthma: A Randomized Controlled Trial. Am. J. Respir. Crit. Care Med. 172: 831-836 [Abstract] [Full Text]  
• Jang, A.-S., Lee, J.-H., Park, S. W., Lee, Y. M., Uh, S. T., Kim, Y.-H., Park, C.-S. (2005). Factors Influencing the Responsiveness to Inhaled Glucocorticoids of Patients With Moderate-to-Severe Asthma. Chest 128: 1140-1145 [Abstract] [Full Text]  
• Fedorov, I A, Wilson, S J, Davies, D E, Holgate, S T (2005). Epithelial stress and structural remodelling in childhood asthma. Thorax 60: 389-394 [Abstract] [Full Text]  
• Currie, G. P., Lee, D. K. C. (2005). The GOAL Study Designed to Favor a Long-acting {beta}2-Agonist?. Am. J. Respir. Crit. Care Med. 171: 1060-1061 [Full Text]  
• Scichilone, N., Messina, M., Battaglia, S., Catalano, F., Bellia, V. (2005). Airway hyperresponsiveness in the elderly: prevalence and clinical implications. Eur Respir J 25: 364-375 [Abstract] [Full Text]  
• Homer, R. J., Elias, J. A. (2005). Airway Remodeling in Asthma: Therapeutic Implications of Mechanisms. Physiology 20: 28-35 [Abstract] [Full Text]  
• James, A. L., Palmer, L. J., Kicic, E., Maxwell, P. S., Lagan, S. E., Ryan, G. F., Musk, A. W. (2005). Decline in Lung Function in the Busselton Health Study: The Effects of Asthma and Cigarette Smoking. Am. J. Respir. Crit. Care Med. 171: 109-114 [Abstract] [Full Text]  
• Reddel, H.K. (2004). Goals of asthma treatment: how high should we go?. Eur Respir J 24: 715-717 [Full Text]  
• Eid, N. S. (2004). Update on National Asthma Education and Prevention Program Pediatric Asthma Treatment Recommendations. CLIN PEDIATR 43: 793-802 [Abstract]  
• Jeffery, P. K. (2004). Remodeling and Inflammation of Bronchi in Asthma and Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 1: 176-183 [Abstract] [Full Text]  
• Chanez, P., Bourdin, A., Vachier, I., Godard, P., Bousquet, J., Vignola, A. M. (2004). Effects of Inhaled Corticosteroids on Pathology in Asthma and Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 1: 184-190 [Abstract] [Full Text]  
• Bateman, E. D., Boushey, H. A., Bousquet, J., Busse, W. W., Clark, T. J. H., Pauwels, R. A., Pedersen, S. E., for the GOAL Investigators Group, (2004). Can Guideline-defined Asthma Control Be Achieved?: The Gaining Optimal Asthma ControL Study. Am. J. Respir. Crit. Care Med. 170: 836-844 [Abstract] [Full Text]  
• Colice, G. L. (2004). Categorizing Asthma Severity: An Overview of National Guidelines. Clin Med Res 2: 155-163 [Abstract] [Full Text]  
• Covar, R. A., Spahn, J. D., Murphy, J. R., Szefler, S. J. (2004). Progression of Asthma Measured by Lung Function in the Childhood Asthma Management Program. Am. J. Respir. Crit. Care Med. 170: 234-241 [Abstract] [Full Text]  
• Cosio, B. G., Mann, B., Ito, K., Jazrawi, E., Barnes, P. J., Chung, K. F., Adcock, I. M. (2004). Histone Acetylase and Deacetylase Activity in Alveolar Macrophages and Blood Mononocytes in Asthma. Am. J. Respir. Crit. Care Med. 170: 141-147 [Abstract] [Full Text]  
• Tamaoki, J., Tagaya, E., Kawatani, K., Nakata, J., Endo, Y., Nagai, A. (2004). Airway Mucosal Thickening and Bronchial Hyperresponsiveness Induced by Inhaled {beta}2-Agonist in Mice. Chest 126: 205-212 [Abstract] [Full Text]  
• Perng, D.-W., Huang, H.-Y., Lee, Y.-C., Perng, R.-P. (2004). Leukotriene Modifier vs Inhaled Corticosteroid in Mild-to-Moderate Asthma: Clinical and Anti-inflammatory Effects. Chest 125: 1693-1699 [Abstract] [Full Text]  
• Pitchford, S. C., Riffo-Vasquez, Y., Sousa, A., Momi, S., Gresele, P., Spina, D., Page, C. P. (2004). Platelets are necessary for airway wall remodeling in a murine model of chronic allergic inflammation. Blood 103: 639-647 [Abstract] [Full Text]  
• Koskela, H. O., Hyvarinen, L., Brannan, J. D., Chan, H.-K., Anderson, S. D. (2003). Responsiveness to Three Bronchial Provocation Tests in Patients With Asthma. Chest 124: 2171-2177 [Abstract] [Full Text]  
• Koskela, H. O., Hyvarinen, L., Brannan, J. D., Chan, H.-K., Anderson, S. D. (2003). Sensitivity and Validity of Three Bronchial Provocation Tests To Demonstrate the Effect of Inhaled Corticosteroids in Asthma. Chest 124: 1341-1349 [Abstract] [Full Text]  
• Jeffery, P., Holgate, S., Wenzel, S. (2003). Methods for the Assessment of Endobronchial Biopsies in Clinical Research: Application to Studies of Pathogenesis and the Effects of Treatment. Am. J. Respir. Crit. Care Med. 168: S1-17 [Full Text]  
• Walters, E H (2003). Publication of complex dataset. Thorax 58: 368-368 [Full Text]  
• Price, D B, Hernandez, D, Magyar, P, Fiterman, J, Beeh, K M, James, I G, Konstantopoulos, S, Rojas, R, van Noord, J A, Pons, M, Gilles, L, Leff, J A (2003). Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma. Thorax 58: 211-216 [Abstract] [Full Text]  
• Strube, G., Ward, C, Reid, D, Walters, E H (2003). Revision of BTS guidelines for treatment of asthma. Thorax 58: 280-280 [Full Text]  
• Chetta, A., Zanini, A., Foresi, A., Del Donno, M., Castagnaro, A., D'Ippolito, R., Baraldo, S., Testi, R., Saetta, M., Olivieri, D. (2003). Vascular Component of Airway Remodeling in Asthma Is Reduced by High Dose of Fluticasone. Am. J. Respir. Crit. Care Med. 167: 751-757 [Abstract] [Full Text]  
• Atkinson, J. J., Senior, R. M. (2003). Matrix Metalloproteinase-9 in Lung Remodeling. Am. J. Respir. Cell Mol. Bio. 28: 12-24 [Abstract] [Full Text]  
• Payne, D. N. R., Rogers, A. V., Adelroth, E., Bandi, V., Guntupalli, K. K., Bush, A., Jeffery, P. K. (2003). Early Thickening of the Reticular Basement Membrane in Children with Difficult Asthma. Am. J. Respir. Crit. Care Med. 167: 78-82 [Abstract] [Full Text]  
• Buist, A.S. (2003). Similarities and differences between asthma and chronic obstructive pulmonary disease: treatment and early outcomes. Eur Respir J 21: 30S-35s [Abstract] [Full Text]  
• (2002). Poster presentations. Thorax 57: iii48-94 [Full Text]  
• Reddel, H K, Marks, G B, Salome, C M, Jenkins, C R, Ward, C, Reid, D, Walters, E H (2002). Inhaled corticosteroid dosage in asthma. Thorax 57: 837-838 [Full Text]  

eLetters:

Read all eLetters

High-dose of Fluticasone propionate in mild asthmatics

S K Agarwal

Thorax Online, 4 Apr 2002 [Full text]